nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—PPARG—colon cancer	0.44	1	CbGaD
Nateglinide—UGT1A9—Irinotecan—colon cancer	0.0739	0.155	CbGbCtD
Nateglinide—SLC16A1—Methotrexate—colon cancer	0.0681	0.143	CbGbCtD
Nateglinide—ABCC4—Fluorouracil—colon cancer	0.0593	0.124	CbGbCtD
Nateglinide—ABCC4—Methotrexate—colon cancer	0.0327	0.0685	CbGbCtD
Nateglinide—CYP3A7—Irinotecan—colon cancer	0.0245	0.0514	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0245	0.0514	CbGbCtD
Nateglinide—ALB—Irinotecan—colon cancer	0.0229	0.048	CbGbCtD
Nateglinide—ALB—Fluorouracil—colon cancer	0.022	0.0461	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0215	0.045	CbGbCtD
Nateglinide—CYP3A7—Vincristine—colon cancer	0.0215	0.045	CbGbCtD
Nateglinide—CYP2C9—Capecitabine—colon cancer	0.02	0.0419	CbGbCtD
Nateglinide—CYP3A5—Irinotecan—colon cancer	0.0184	0.0386	CbGbCtD
Nateglinide—CYP3A5—Vincristine—colon cancer	0.0161	0.0337	CbGbCtD
Nateglinide—SLC22A6—Methotrexate—colon cancer	0.0142	0.0298	CbGbCtD
Nateglinide—ALB—Methotrexate—colon cancer	0.0121	0.0254	CbGbCtD
Nateglinide—CYP2C9—Fluorouracil—colon cancer	0.0118	0.0248	CbGbCtD
Nateglinide—CYP3A4—Irinotecan—colon cancer	0.00718	0.015	CbGbCtD
Nateglinide—CYP3A4—Vincristine—colon cancer	0.00627	0.0132	CbGbCtD
Nateglinide—ORM1—bile—colon cancer	0.0056	0.124	CbGeAlD
Nateglinide—PPARG—Topotecan—Irinotecan—colon cancer	0.00287	1	CbGdCrCtD
Nateglinide—PPARG—endothelium—colon cancer	0.00167	0.037	CbGeAlD
Nateglinide—ORM1—gall bladder—colon cancer	0.00155	0.0343	CbGeAlD
Nateglinide—PPARG—blood vessel—colon cancer	0.00154	0.0341	CbGeAlD
Nateglinide—UGT1A9—renal system—colon cancer	0.00142	0.0313	CbGeAlD
Nateglinide—ALB—gall bladder—colon cancer	0.00136	0.0301	CbGeAlD
Nateglinide—UGT1A9—digestive system—colon cancer	0.00116	0.0257	CbGeAlD
Nateglinide—Hepatitis cholestatic—Capecitabine—colon cancer	0.0011	0.0419	CcSEcCtD
Nateglinide—Gastrointestinal symptom NOS—Fluorouracil—colon cancer	0.00108	0.041	CcSEcCtD
Nateglinide—Mitiglinide—PPARG—colon cancer	0.000977	0.501	CrCbGaD
Nateglinide—ABCC8—smooth muscle tissue—colon cancer	0.000948	0.0209	CbGeAlD
Nateglinide—SLC15A1—epithelium—colon cancer	0.000941	0.0208	CbGeAlD
Nateglinide—PPARG—embryo—colon cancer	0.000921	0.0203	CbGeAlD
Nateglinide—ABCC8—renal system—colon cancer	0.000913	0.0202	CbGeAlD
Nateglinide—SLC16A1—epithelium—colon cancer	0.000895	0.0198	CbGeAlD
Nateglinide—PTGS1—endothelium—colon cancer	0.000895	0.0198	CbGeAlD
Nateglinide—SLC15A1—renal system—colon cancer	0.000873	0.0193	CbGeAlD
Nateglinide—UGT1A9—liver—colon cancer	0.000866	0.0191	CbGeAlD
Nateglinide—SLC16A1—renal system—colon cancer	0.00083	0.0183	CbGeAlD
Nateglinide—PTGS1—blood vessel—colon cancer	0.000825	0.0182	CbGeAlD
Nateglinide—KCNJ11—lymphoid tissue—colon cancer	0.000823	0.0182	CbGeAlD
Nateglinide—PPARG—epithelium—colon cancer	0.000751	0.0166	CbGeAlD
Nateglinide—PPARG—smooth muscle tissue—colon cancer	0.000724	0.016	CbGeAlD
Nateglinide—CYP3A7—liver—colon cancer	0.00072	0.0159	CbGeAlD
Nateglinide—SLC15A1—digestive system—colon cancer	0.000716	0.0158	CbGeAlD
Nateglinide—PPARG—renal system—colon cancer	0.000697	0.0154	CbGeAlD
Nateglinide—SLC16A1—digestive system—colon cancer	0.000681	0.015	CbGeAlD
Nateglinide—ABCC4—renal system—colon cancer	0.000633	0.014	CbGeAlD
Nateglinide—SLC15A1—vagina—colon cancer	0.000632	0.014	CbGeAlD
Nateglinide—Urine output increased—Vincristine—colon cancer	0.000614	0.0234	CcSEcCtD
Nateglinide—CYP3A7-CYP3A51P—liver—colon cancer	0.000612	0.0135	CbGeAlD
Nateglinide—PPARG—lymphoid tissue—colon cancer	0.000579	0.0128	CbGeAlD
Nateglinide—PPARG—digestive system—colon cancer	0.000571	0.0126	CbGeAlD
Nateglinide—ORM1—bone marrow—colon cancer	0.000564	0.0124	CbGeAlD
Nateglinide—Polyuria—Vincristine—colon cancer	0.000561	0.0214	CcSEcCtD
Nateglinide—SLC15A2—renal system—colon cancer	0.000546	0.012	CbGeAlD
Nateglinide—SLC15A1—liver—colon cancer	0.000533	0.0118	CbGeAlD
Nateglinide—PPARG—bone marrow—colon cancer	0.000527	0.0116	CbGeAlD
Nateglinide—Injury—Irinotecan—colon cancer	0.000522	0.0199	CcSEcCtD
Nateglinide—ABCC4—digestive system—colon cancer	0.000519	0.0115	CbGeAlD
Nateglinide—SLC16A1—liver—colon cancer	0.000507	0.0112	CbGeAlD
Nateglinide—PPARG—vagina—colon cancer	0.000505	0.0111	CbGeAlD
Nateglinide—Osteoarthritis—Irinotecan—colon cancer	0.00048	0.0183	CcSEcCtD
Nateglinide—ABCC4—bone marrow—colon cancer	0.000478	0.0106	CbGeAlD
Nateglinide—KCNJ11—lymph node—colon cancer	0.000464	0.0103	CbGeAlD
Nateglinide—Osteoarthritis—Fluorouracil—colon cancer	0.00046	0.0175	CcSEcCtD
Nateglinide—ORM1—liver—colon cancer	0.000455	0.0101	CbGeAlD
Nateglinide—PPARG—liver—colon cancer	0.000426	0.0094	CbGeAlD
Nateglinide—CYP3A5—renal system—colon cancer	0.000415	0.00915	CbGeAlD
Nateglinide—Sweating increased—Irinotecan—colon cancer	0.000404	0.0154	CcSEcCtD
Nateglinide—PTGS1—epithelium—colon cancer	0.000402	0.00887	CbGeAlD
Nateglinide—Urine output increased—Capecitabine—colon cancer	0.0004	0.0152	CcSEcCtD
Nateglinide—ALB—liver—colon cancer	0.000399	0.00882	CbGeAlD
Nateglinide—SLC15A2—vagina—colon cancer	0.000395	0.00872	CbGeAlD
Nateglinide—SLC16A1—lymph node—colon cancer	0.000389	0.00859	CbGeAlD
Nateglinide—PTGS1—smooth muscle tissue—colon cancer	0.000387	0.00854	CbGeAlD
Nateglinide—ABCC4—liver—colon cancer	0.000387	0.00854	CbGeAlD
Nateglinide—Upper respiratory tract infection—Irinotecan—colon cancer	0.000385	0.0147	CcSEcCtD
Nateglinide—PTGS1—renal system—colon cancer	0.000372	0.00823	CbGeAlD
Nateglinide—Neuropathy peripheral—Vincristine—colon cancer	0.000372	0.0142	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Fluorouracil—colon cancer	0.000369	0.0141	CcSEcCtD
Nateglinide—Polyuria—Capecitabine—colon cancer	0.000366	0.0139	CcSEcCtD
Nateglinide—Sweating—Vincristine—colon cancer	0.000364	0.0139	CcSEcCtD
Nateglinide—Jaundice—Irinotecan—colon cancer	0.00036	0.0137	CcSEcCtD
Nateglinide—Cilazapril—ABCB1—colon cancer	0.000357	0.183	CrCbGaD
Nateglinide—Lisinopril—ABCB1—colon cancer	0.000357	0.183	CrCbGaD
Nateglinide—Sweating—Irinotecan—colon cancer	0.000355	0.0135	CcSEcCtD
Nateglinide—ORM1—lymph node—colon cancer	0.000349	0.00771	CbGeAlD
Nateglinide—Hepatic enzyme increased—Methotrexate—colon cancer	0.000348	0.0133	CcSEcCtD
Nateglinide—Neuropathy peripheral—Fluorouracil—colon cancer	0.000347	0.0132	CcSEcCtD
Nateglinide—Increased appetite—Capecitabine—colon cancer	0.000342	0.013	CcSEcCtD
Nateglinide—CYP3A5—digestive system—colon cancer	0.00034	0.00751	CbGeAlD
Nateglinide—Thirst—Capecitabine—colon cancer	0.000337	0.0129	CcSEcCtD
Nateglinide—CYP2C9—digestive system—colon cancer	0.000335	0.00739	CbGeAlD
Nateglinide—PPARG—lymph node—colon cancer	0.000326	0.00721	CbGeAlD
Nateglinide—Osteoarthritis—Capecitabine—colon cancer	0.000321	0.0122	CcSEcCtD
Nateglinide—CYP3A4—renal system—colon cancer	0.000311	0.00687	CbGeAlD
Nateglinide—ALB—lymph node—colon cancer	0.000306	0.00676	CbGeAlD
Nateglinide—CYP2D6—renal system—colon cancer	0.000306	0.00676	CbGeAlD
Nateglinide—PTGS1—digestive system—colon cancer	0.000306	0.00675	CbGeAlD
Nateglinide—CYP3A5—vagina—colon cancer	0.0003	0.00663	CbGeAlD
Nateglinide—Immune system disorder—Irinotecan—colon cancer	0.0003	0.0114	CcSEcCtD
Nateglinide—Urine output increased—Methotrexate—colon cancer	0.000298	0.0113	CcSEcCtD
Nateglinide—ABCC4—lymph node—colon cancer	0.000296	0.00655	CbGeAlD
Nateglinide—Back pain—Vincristine—colon cancer	0.000287	0.0109	CcSEcCtD
Nateglinide—Back pain—Irinotecan—colon cancer	0.00028	0.0107	CcSEcCtD
Nateglinide—Influenza—Capecitabine—colon cancer	0.000278	0.0106	CcSEcCtD
Nateglinide—Polyuria—Methotrexate—colon cancer	0.000272	0.0104	CcSEcCtD
Nateglinide—Sweating increased—Capecitabine—colon cancer	0.00027	0.0103	CcSEcCtD
Nateglinide—PTGS1—vagina—colon cancer	0.00027	0.00596	CbGeAlD
Nateglinide—Bronchitis—Capecitabine—colon cancer	0.000267	0.0102	CcSEcCtD
Nateglinide—Enalapril—ABCB1—colon cancer	0.000262	0.134	CrCbGaD
Nateglinide—Upper respiratory tract infection—Capecitabine—colon cancer	0.000258	0.00983	CcSEcCtD
Nateglinide—SLC15A2—lymph node—colon cancer	0.000256	0.00564	CbGeAlD
Nateglinide—CYP3A4—digestive system—colon cancer	0.000255	0.00563	CbGeAlD
Nateglinide—CYP3A5—liver—colon cancer	0.000253	0.00559	CbGeAlD
Nateglinide—Cough—Irinotecan—colon cancer	0.000252	0.00961	CcSEcCtD
Nateglinide—CYP2D6—digestive system—colon cancer	0.000251	0.00554	CbGeAlD
Nateglinide—CYP2C9—liver—colon cancer	0.000249	0.00551	CbGeAlD
Nateglinide—Neuropathy peripheral—Capecitabine—colon cancer	0.000243	0.00924	CcSEcCtD
Nateglinide—Jaundice—Capecitabine—colon cancer	0.000241	0.00919	CcSEcCtD
Nateglinide—Osteoarthritis—Methotrexate—colon cancer	0.000239	0.00911	CcSEcCtD
Nateglinide—Hyperhidrosis—Vincristine—colon cancer	0.000234	0.00892	CcSEcCtD
Nateglinide—Hepatobiliary disease—Capecitabine—colon cancer	0.000234	0.00892	CcSEcCtD
Nateglinide—Hyperhidrosis—Irinotecan—colon cancer	0.000228	0.00869	CcSEcCtD
Nateglinide—Oedema peripheral—Capecitabine—colon cancer	0.000219	0.00834	CcSEcCtD
Nateglinide—Erythema multiforme—Capecitabine—colon cancer	0.00021	0.008	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Vincristine—colon cancer	0.000209	0.00797	CcSEcCtD
Nateglinide—Fatigue—Vincristine—colon cancer	0.000209	0.00796	CcSEcCtD
Nateglinide—Dyspepsia—Irinotecan—colon cancer	0.000208	0.00791	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Irinotecan—colon cancer	0.000204	0.00776	CcSEcCtD
Nateglinide—Fatigue—Irinotecan—colon cancer	0.000203	0.00775	CcSEcCtD
Nateglinide—Immune system disorder—Capecitabine—colon cancer	0.000201	0.00765	CcSEcCtD
Nateglinide—Dyspepsia—Fluorouracil—colon cancer	0.000199	0.00758	CcSEcCtD
Nateglinide—Gastrointestinal pain—Vincristine—colon cancer	0.000198	0.00755	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000195	0.00743	CcSEcCtD
Nateglinide—Malnutrition—Capecitabine—colon cancer	0.000193	0.00737	CcSEcCtD
Nateglinide—Gastrointestinal pain—Irinotecan—colon cancer	0.000193	0.00735	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Methotrexate—colon cancer	0.000192	0.00732	CcSEcCtD
Nateglinide—Abdominal pain—Vincristine—colon cancer	0.000191	0.00729	CcSEcCtD
Nateglinide—CYP3A4—liver—colon cancer	0.00019	0.0042	CbGeAlD
Nateglinide—Back pain—Capecitabine—colon cancer	0.000187	0.00713	CcSEcCtD
Nateglinide—CYP2D6—liver—colon cancer	0.000187	0.00413	CbGeAlD
Nateglinide—Abdominal pain—Irinotecan—colon cancer	0.000186	0.0071	CcSEcCtD
Nateglinide—Tremor—Capecitabine—colon cancer	0.000181	0.0069	CcSEcCtD
Nateglinide—Urticaria—Fluorouracil—colon cancer	0.000179	0.00684	CcSEcCtD
Nateglinide—Hypersensitivity—Vincristine—colon cancer	0.000178	0.0068	CcSEcCtD
Nateglinide—Sweating—Methotrexate—colon cancer	0.000177	0.00673	CcSEcCtD
Nateglinide—PTGS1—lymph node—colon cancer	0.000175	0.00385	CbGeAlD
Nateglinide—Hepatobiliary disease—Methotrexate—colon cancer	0.000174	0.00664	CcSEcCtD
Nateglinide—Hypersensitivity—Irinotecan—colon cancer	0.000174	0.00662	CcSEcCtD
Nateglinide—Asthenia—Vincristine—colon cancer	0.000174	0.00662	CcSEcCtD
Nateglinide—Palpitations—Capecitabine—colon cancer	0.000171	0.00651	CcSEcCtD
Nateglinide—Asthenia—Irinotecan—colon cancer	0.000169	0.00645	CcSEcCtD
Nateglinide—Cough—Capecitabine—colon cancer	0.000169	0.00643	CcSEcCtD
Nateglinide—Hypersensitivity—Fluorouracil—colon cancer	0.000166	0.00634	CcSEcCtD
Nateglinide—Diarrhoea—Vincristine—colon cancer	0.000166	0.00631	CcSEcCtD
Nateglinide—Diarrhoea—Irinotecan—colon cancer	0.000161	0.00615	CcSEcCtD
Nateglinide—Dizziness—Vincristine—colon cancer	0.00016	0.0061	CcSEcCtD
Nateglinide—Pruritus—Fluorouracil—colon cancer	0.00016	0.00609	CcSEcCtD
Nateglinide—Erythema multiforme—Methotrexate—colon cancer	0.000156	0.00596	CcSEcCtD
Nateglinide—Dizziness—Irinotecan—colon cancer	0.000156	0.00594	CcSEcCtD
Nateglinide—Diarrhoea—Fluorouracil—colon cancer	0.000155	0.00589	CcSEcCtD
Nateglinide—Vomiting—Vincristine—colon cancer	0.000154	0.00587	CcSEcCtD
Nateglinide—Rash—Vincristine—colon cancer	0.000153	0.00582	CcSEcCtD
Nateglinide—Hyperhidrosis—Capecitabine—colon cancer	0.000153	0.00581	CcSEcCtD
Nateglinide—Dermatitis—Vincristine—colon cancer	0.000153	0.00581	CcSEcCtD
Nateglinide—Vomiting—Irinotecan—colon cancer	0.00015	0.00571	CcSEcCtD
Nateglinide—Immune system disorder—Methotrexate—colon cancer	0.000149	0.00569	CcSEcCtD
Nateglinide—Dizziness—Fluorouracil—colon cancer	0.000149	0.00569	CcSEcCtD
Nateglinide—Rash—Irinotecan—colon cancer	0.000149	0.00567	CcSEcCtD
Nateglinide—Dermatitis—Irinotecan—colon cancer	0.000149	0.00566	CcSEcCtD
Nateglinide—Malnutrition—Methotrexate—colon cancer	0.000144	0.00549	CcSEcCtD
Nateglinide—Nausea—Vincristine—colon cancer	0.000144	0.00548	CcSEcCtD
Nateglinide—Vomiting—Fluorouracil—colon cancer	0.000144	0.00547	CcSEcCtD
Nateglinide—Rash—Fluorouracil—colon cancer	0.000142	0.00543	CcSEcCtD
Nateglinide—Dermatitis—Fluorouracil—colon cancer	0.000142	0.00542	CcSEcCtD
Nateglinide—Nausea—Irinotecan—colon cancer	0.00014	0.00534	CcSEcCtD
Nateglinide—Back pain—Methotrexate—colon cancer	0.000139	0.00531	CcSEcCtD
Nateglinide—Dyspepsia—Capecitabine—colon cancer	0.000139	0.00529	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Capecitabine—colon cancer	0.000136	0.00519	CcSEcCtD
Nateglinide—Fatigue—Capecitabine—colon cancer	0.000136	0.00519	CcSEcCtD
Nateglinide—Nausea—Fluorouracil—colon cancer	0.000134	0.00511	CcSEcCtD
Nateglinide—Gastrointestinal pain—Capecitabine—colon cancer	0.000129	0.00492	CcSEcCtD
Nateglinide—Cough—Methotrexate—colon cancer	0.000126	0.00479	CcSEcCtD
Nateglinide—Urticaria—Capecitabine—colon cancer	0.000125	0.00478	CcSEcCtD
Nateglinide—Abdominal pain—Capecitabine—colon cancer	0.000125	0.00475	CcSEcCtD
Nateglinide—Hypersensitivity—Capecitabine—colon cancer	0.000116	0.00443	CcSEcCtD
Nateglinide—Hyperhidrosis—Methotrexate—colon cancer	0.000114	0.00433	CcSEcCtD
Nateglinide—Asthenia—Capecitabine—colon cancer	0.000113	0.00432	CcSEcCtD
Nateglinide—Pruritus—Capecitabine—colon cancer	0.000112	0.00426	CcSEcCtD
Nateglinide—Diarrhoea—Capecitabine—colon cancer	0.000108	0.00412	CcSEcCtD
Nateglinide—Dizziness—Capecitabine—colon cancer	0.000104	0.00398	CcSEcCtD
Nateglinide—Dyspepsia—Methotrexate—colon cancer	0.000103	0.00394	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Methotrexate—colon cancer	0.000101	0.00387	CcSEcCtD
Nateglinide—Fatigue—Methotrexate—colon cancer	0.000101	0.00386	CcSEcCtD
Nateglinide—Vomiting—Capecitabine—colon cancer	0.0001	0.00382	CcSEcCtD
Nateglinide—Rash—Capecitabine—colon cancer	9.95e-05	0.00379	CcSEcCtD
Nateglinide—Dermatitis—Capecitabine—colon cancer	9.94e-05	0.00379	CcSEcCtD
Nateglinide—Gastrointestinal pain—Methotrexate—colon cancer	9.61e-05	0.00366	CcSEcCtD
Nateglinide—Nausea—Capecitabine—colon cancer	9.38e-05	0.00357	CcSEcCtD
Nateglinide—Urticaria—Methotrexate—colon cancer	9.34e-05	0.00356	CcSEcCtD
Nateglinide—Abdominal pain—Methotrexate—colon cancer	9.29e-05	0.00354	CcSEcCtD
Nateglinide—Hypersensitivity—Methotrexate—colon cancer	8.66e-05	0.0033	CcSEcCtD
Nateglinide—Asthenia—Methotrexate—colon cancer	8.43e-05	0.00321	CcSEcCtD
Nateglinide—Pruritus—Methotrexate—colon cancer	8.31e-05	0.00317	CcSEcCtD
Nateglinide—Diarrhoea—Methotrexate—colon cancer	8.04e-05	0.00306	CcSEcCtD
Nateglinide—Dizziness—Methotrexate—colon cancer	7.77e-05	0.00296	CcSEcCtD
Nateglinide—Vomiting—Methotrexate—colon cancer	7.47e-05	0.00285	CcSEcCtD
Nateglinide—Rash—Methotrexate—colon cancer	7.41e-05	0.00282	CcSEcCtD
Nateglinide—Dermatitis—Methotrexate—colon cancer	7.4e-05	0.00282	CcSEcCtD
Nateglinide—Nausea—Methotrexate—colon cancer	6.98e-05	0.00266	CcSEcCtD
Nateglinide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	2.82e-05	0.004	CbGpPWpGaD
Nateglinide—PPARG—Signaling events mediated by HDAC Class I—EP300—colon cancer	2.81e-05	0.00399	CbGpPWpGaD
Nateglinide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	2.81e-05	0.00398	CbGpPWpGaD
Nateglinide—SLC16A1—Cell surface interactions at the vascular wall—SRC—colon cancer	2.76e-05	0.00392	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CA7—colon cancer	2.76e-05	0.00392	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	2.73e-05	0.00387	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CHST5—colon cancer	2.72e-05	0.00385	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—ODC1—colon cancer	2.72e-05	0.00385	CbGpPWpGaD
Nateglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	2.67e-05	0.00379	CbGpPWpGaD
Nateglinide—SLC16A1—Cell surface interactions at the vascular wall—NRAS—colon cancer	2.66e-05	0.00377	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—ODC1—colon cancer	2.64e-05	0.00374	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CHST5—colon cancer	2.64e-05	0.00374	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—TYMS—colon cancer	2.61e-05	0.0037	CbGpPWpGaD
Nateglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—colon cancer	2.61e-05	0.00369	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—ODC1—colon cancer	2.6e-05	0.00368	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CHST5—colon cancer	2.6e-05	0.00368	CbGpPWpGaD
Nateglinide—UGT1A9—PPARA activates gene expression—PPARG—colon cancer	2.57e-05	0.00365	CbGpPWpGaD
Nateglinide—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	2.52e-05	0.00357	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—DCC—colon cancer	2.46e-05	0.00349	CbGpPWpGaD
Nateglinide—ABCC4—Platelet degranulation—VEGFA—colon cancer	2.38e-05	0.00337	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CA7—colon cancer	2.32e-05	0.00329	CbGpPWpGaD
Nateglinide—SLC16A1—Cell surface interactions at the vascular wall—KRAS—colon cancer	2.29e-05	0.00324	CbGpPWpGaD
Nateglinide—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	2.27e-05	0.00321	CbGpPWpGaD
Nateglinide—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—colon cancer	2.27e-05	0.00321	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CA7—colon cancer	2.25e-05	0.00319	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—HNF4A—colon cancer	2.2e-05	0.00312	CbGpPWpGaD
Nateglinide—ABCC4—Platelet degranulation—TGFB1—colon cancer	2.18e-05	0.0031	CbGpPWpGaD
Nateglinide—PPARG—Wnt Signaling Pathway Netpath—AKT1—colon cancer	2.16e-05	0.00306	CbGpPWpGaD
Nateglinide—PPARG—SREBP signalling—PIK3CA—colon cancer	2.1e-05	0.00298	CbGpPWpGaD
Nateglinide—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—colon cancer	2.1e-05	0.00298	CbGpPWpGaD
Nateglinide—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	2.08e-05	0.00295	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—HNF4A—colon cancer	2.07e-05	0.00294	CbGpPWpGaD
Nateglinide—PTGS1—Selenium Micronutrient Network—PTGS2—colon cancer	1.97e-05	0.0028	CbGpPWpGaD
Nateglinide—PPARG—PPARA activates gene expression—EP300—colon cancer	1.96e-05	0.00278	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ODC1—colon cancer	1.95e-05	0.00276	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CHST5—colon cancer	1.95e-05	0.00276	CbGpPWpGaD
Nateglinide—SLC16A1—Cell surface interactions at the vascular wall—HRAS—colon cancer	1.95e-05	0.00276	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—BRAF—colon cancer	1.93e-05	0.00274	CbGpPWpGaD
Nateglinide—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	1.92e-05	0.00272	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—BRAF—colon cancer	1.87e-05	0.00266	CbGpPWpGaD
Nateglinide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	1.86e-05	0.00264	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—CTNNB1—colon cancer	1.84e-05	0.00261	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—CDKN1A—colon cancer	1.8e-05	0.00255	CbGpPWpGaD
Nateglinide—ABCC4—Ectoderm Differentiation—CTNNB1—colon cancer	1.75e-05	0.00248	CbGpPWpGaD
Nateglinide—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	1.74e-05	0.00246	CbGpPWpGaD
Nateglinide—PPARG—SREBP signalling—AKT1—colon cancer	1.72e-05	0.00244	CbGpPWpGaD
Nateglinide—UGT1A9—PPARA activates gene expression—EP300—colon cancer	1.68e-05	0.00239	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CA7—colon cancer	1.68e-05	0.00238	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CHST5—colon cancer	1.67e-05	0.00237	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ODC1—colon cancer	1.67e-05	0.00237	CbGpPWpGaD
Nateglinide—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	1.65e-05	0.00233	CbGpPWpGaD
Nateglinide—CYP2C9—Arachidonic acid metabolism—PTGS2—colon cancer	1.63e-05	0.00231	CbGpPWpGaD
Nateglinide—ABCC8—Transmembrane transport of small molecules—ABCB1—colon cancer	1.53e-05	0.00217	CbGpPWpGaD
Nateglinide—PPARG—Adipogenesis—TGFB1—colon cancer	1.49e-05	0.00211	CbGpPWpGaD
Nateglinide—SLC16A1—Transmembrane transport of small molecules—ABCB1—colon cancer	1.47e-05	0.00208	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CA7—colon cancer	1.45e-05	0.00205	CbGpPWpGaD
Nateglinide—ABCC4—Ectoderm Differentiation—MYC—colon cancer	1.42e-05	0.00201	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ODC1—colon cancer	1.41e-05	0.00199	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CHST5—colon cancer	1.41e-05	0.00199	CbGpPWpGaD
Nateglinide—SLC15A2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.38e-05	0.00196	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CHST5—colon cancer	1.36e-05	0.00193	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ODC1—colon cancer	1.36e-05	0.00193	CbGpPWpGaD
Nateglinide—ABCC4—NRF2 pathway—TGFB1—colon cancer	1.35e-05	0.00191	CbGpPWpGaD
Nateglinide—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	1.32e-05	0.00187	CbGpPWpGaD
Nateglinide—SLC15A1—Transmembrane transport of small molecules—ABCB1—colon cancer	1.28e-05	0.00182	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	1.27e-05	0.0018	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—EP300—colon cancer	1.21e-05	0.00171	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CA7—colon cancer	1.19e-05	0.00169	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CA7—colon cancer	1.18e-05	0.00168	CbGpPWpGaD
Nateglinide—UGT1A9—NRF2 pathway—TGFB1—colon cancer	1.17e-05	0.00165	CbGpPWpGaD
Nateglinide—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	1.14e-05	0.00161	CbGpPWpGaD
Nateglinide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	1.11e-05	0.00157	CbGpPWpGaD
Nateglinide—ABCC4—Transmembrane transport of small molecules—ABCB1—colon cancer	1.09e-05	0.00155	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—SRC—colon cancer	1.08e-05	0.00154	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—VEGFA—colon cancer	1.08e-05	0.00153	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—HNF4A—colon cancer	1.06e-05	0.0015	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—VEGFA—colon cancer	1.06e-05	0.0015	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	1.03e-05	0.00145	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ODC1—colon cancer	1.02e-05	0.00144	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CHST5—colon cancer	1.02e-05	0.00144	CbGpPWpGaD
Nateglinide—ALB—Platelet degranulation—TGFB1—colon cancer	9.89e-06	0.0014	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—TGFB1—colon cancer	9.69e-06	0.00137	CbGpPWpGaD
Nateglinide—SLC22A6—Transmembrane transport of small molecules—ABCB1—colon cancer	9.51e-06	0.00135	CbGpPWpGaD
Nateglinide—ALB—Folate Metabolism—TP53—colon cancer	9.49e-06	0.00135	CbGpPWpGaD
Nateglinide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	9.42e-06	0.00133	CbGpPWpGaD
Nateglinide—ABCC8—Neuronal System—HRAS—colon cancer	8.89e-06	0.00126	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ODC1—colon cancer	8.76e-06	0.00124	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CHST5—colon cancer	8.76e-06	0.00124	CbGpPWpGaD
Nateglinide—PPARG—Circadian rythm related genes—TP53—colon cancer	8.66e-06	0.00123	CbGpPWpGaD
Nateglinide—KCNJ11—Neuronal System—HRAS—colon cancer	8.62e-06	0.00122	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	8.25e-06	0.00117	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CA7—colon cancer	7.81e-06	0.00111	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—EP300—colon cancer	7.71e-06	0.00109	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—SRC—colon cancer	7.49e-06	0.00106	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—VEGFA—colon cancer	7.3e-06	0.00103	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CHST5—colon cancer	7.24e-06	0.00103	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ODC1—colon cancer	7.24e-06	0.00103	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—NRAS—colon cancer	7.21e-06	0.00102	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—ABCB1—colon cancer	7.18e-06	0.00102	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CHST5—colon cancer	7.17e-06	0.00102	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ODC1—colon cancer	7.17e-06	0.00102	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—TYMS—colon cancer	7.05e-06	0.001	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—ABCB1—colon cancer	6.97e-06	0.000987	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.91e-06	0.000979	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—ABCB1—colon cancer	6.86e-06	0.000973	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—TYMS—colon cancer	6.84e-06	0.000969	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—TYMS—colon cancer	6.74e-06	0.000955	CbGpPWpGaD
Nateglinide—ABCC4—Platelet activation, signaling and aggregation—AKT1—colon cancer	6.74e-06	0.000955	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TGFB1—colon cancer	6.7e-06	0.000949	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—CTNNB1—colon cancer	6.34e-06	0.000898	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.33e-06	0.000896	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—KRAS—colon cancer	6.21e-06	0.000879	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—EP300—colon cancer	5.89e-06	0.000835	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—EP300—colon cancer	5.75e-06	0.000814	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—SRC—colon cancer	5.73e-06	0.000812	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—PIK3CA—colon cancer	5.7e-06	0.000808	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.63e-06	0.000798	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—SRC—colon cancer	5.59e-06	0.000792	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—VEGFA—colon cancer	5.58e-06	0.000791	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—TP53—colon cancer	5.52e-06	0.000782	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—NRAS—colon cancer	5.51e-06	0.000781	CbGpPWpGaD
Nateglinide—PPARG—Generic Transcription Pathway—MYC—colon cancer	5.45e-06	0.000773	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—VEGFA—colon cancer	5.44e-06	0.000771	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.44e-06	0.00077	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—NRAS—colon cancer	5.38e-06	0.000762	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—HRAS—colon cancer	5.27e-06	0.000747	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.26e-06	0.000746	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—ABCB1—colon cancer	5.15e-06	0.000729	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—TGFB1—colon cancer	5.12e-06	0.000726	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—TYMS—colon cancer	5.06e-06	0.000716	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—EGFR—colon cancer	5.02e-06	0.000712	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PPARG—colon cancer	5e-06	0.000708	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TGFB1—colon cancer	5e-06	0.000708	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	4.95e-06	0.000701	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	4.91e-06	0.000695	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PPARG—colon cancer	4.85e-06	0.000687	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	4.78e-06	0.000677	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PPARG—colon cancer	4.78e-06	0.000677	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—KRAS—colon cancer	4.74e-06	0.000672	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ODC1—colon cancer	4.73e-06	0.00067	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CHST5—colon cancer	4.73e-06	0.00067	CbGpPWpGaD
Nateglinide—SLC16A1—Hemostasis—AKT1—colon cancer	4.66e-06	0.00066	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—KRAS—colon cancer	4.63e-06	0.000656	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.52e-06	0.000641	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.43e-06	0.000628	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—ABCB1—colon cancer	4.42e-06	0.000627	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	4.39e-06	0.000621	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—TYMS—colon cancer	4.34e-06	0.000616	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—PIK3CA—colon cancer	4.25e-06	0.000602	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—TP53—colon cancer	4.11e-06	0.000583	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—HRAS—colon cancer	4.03e-06	0.000571	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—HRAS—colon cancer	3.93e-06	0.000557	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PTGS2—colon cancer	3.93e-06	0.000557	CbGpPWpGaD
Nateglinide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.89e-06	0.000552	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PTGS2—colon cancer	3.81e-06	0.00054	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PTGS2—colon cancer	3.76e-06	0.000532	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	3.73e-06	0.000529	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ABCB1—colon cancer	3.72e-06	0.000527	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.69e-06	0.000522	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—TYMS—colon cancer	3.65e-06	0.000518	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.62e-06	0.000513	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ABCB1—colon cancer	3.61e-06	0.000511	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—AKT1—colon cancer	3.56e-06	0.000504	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—TYMS—colon cancer	3.54e-06	0.000502	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—AKT1—colon cancer	3.47e-06	0.000492	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.34e-06	0.000474	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—EP300—colon cancer	3.27e-06	0.000463	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—EP300—colon cancer	3.17e-06	0.000449	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—EP300—colon cancer	3.12e-06	0.000443	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PPARG—colon cancer	3.08e-06	0.000436	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	3.05e-06	0.000432	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.96e-06	0.00042	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.85e-06	0.000403	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PTGS2—colon cancer	2.82e-06	0.000399	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.73e-06	0.000386	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ABCB1—colon cancer	2.69e-06	0.000381	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—TYMS—colon cancer	2.64e-06	0.000374	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MYC—colon cancer	2.63e-06	0.000372	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—EP300—colon cancer	2.6e-06	0.000368	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PPARG—colon cancer	2.59e-06	0.000367	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SRC—colon cancer	2.53e-06	0.000358	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PPARG—colon cancer	2.51e-06	0.000356	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—colon cancer	2.46e-06	0.000349	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—NRAS—colon cancer	2.43e-06	0.000345	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTGS2—colon cancer	2.42e-06	0.000343	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CA—colon cancer	2.42e-06	0.000343	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.37e-06	0.000335	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CA—colon cancer	2.35e-06	0.000332	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—EP300—colon cancer	2.34e-06	0.000332	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.33e-06	0.00033	CbGpPWpGaD
Nateglinide—ALB—Metabolism—ABCB1—colon cancer	2.32e-06	0.000328	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CA—colon cancer	2.31e-06	0.000328	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TYMS—colon cancer	2.27e-06	0.000322	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TGFB1—colon cancer	2.26e-06	0.00032	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—KRAS—colon cancer	2.09e-06	0.000297	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS2—colon cancer	2.04e-06	0.000289	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—EP300—colon cancer	2.01e-06	0.000285	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AKT1—colon cancer	1.98e-06	0.00028	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTGS2—colon cancer	1.97e-06	0.00028	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.94e-06	0.000275	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CA—colon cancer	1.92e-06	0.000273	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AKT1—colon cancer	1.92e-06	0.000271	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ABCB1—colon cancer	1.91e-06	0.000271	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ABCB1—colon cancer	1.9e-06	0.000269	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—AKT1—colon cancer	1.89e-06	0.000268	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TYMS—colon cancer	1.88e-06	0.000266	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPARG—colon cancer	1.87e-06	0.000265	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TYMS—colon cancer	1.86e-06	0.000264	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TP53—colon cancer	1.86e-06	0.000264	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—AKT1—colon cancer	1.82e-06	0.000258	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—HRAS—colon cancer	1.78e-06	0.000252	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.75e-06	0.000248	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CA—colon cancer	1.73e-06	0.000246	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—EP300—colon cancer	1.69e-06	0.00024	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—EP300—colon cancer	1.64e-06	0.000233	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPARG—colon cancer	1.61e-06	0.000228	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—AKT1—colon cancer	1.57e-06	0.000223	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CA—colon cancer	1.49e-06	0.000211	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS2—colon cancer	1.47e-06	0.000209	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.43e-06	0.000203	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AKT1—colon cancer	1.42e-06	0.000201	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPARG—colon cancer	1.33e-06	0.000189	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPARG—colon cancer	1.32e-06	0.000187	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS2—colon cancer	1.27e-06	0.00018	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CA—colon cancer	1.25e-06	0.000178	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ABCB1—colon cancer	1.25e-06	0.000177	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TYMS—colon cancer	1.23e-06	0.000174	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—EP300—colon cancer	1.22e-06	0.000173	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKT1—colon cancer	1.22e-06	0.000172	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CA—colon cancer	1.21e-06	0.000172	CbGpPWpGaD
Nateglinide—ALB—Metabolism—EP300—colon cancer	1.05e-06	0.000149	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS2—colon cancer	1.05e-06	0.000148	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS2—colon cancer	1.04e-06	0.000147	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKT1—colon cancer	1.02e-06	0.000145	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKT1—colon cancer	9.92e-07	0.000141	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CA—colon cancer	9.06e-07	0.000128	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—EP300—colon cancer	8.7e-07	0.000123	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPARG—colon cancer	8.7e-07	0.000123	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—EP300—colon cancer	8.63e-07	0.000122	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CA—colon cancer	7.8e-07	0.000111	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKT1—colon cancer	7.4e-07	0.000105	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS2—colon cancer	6.84e-07	9.7e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CA—colon cancer	6.44e-07	9.12e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CA—colon cancer	6.38e-07	9.05e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKT1—colon cancer	6.37e-07	9.03e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—EP300—colon cancer	5.69e-07	8.06e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKT1—colon cancer	5.26e-07	7.45e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKT1—colon cancer	5.21e-07	7.39e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CA—colon cancer	4.21e-07	5.97e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKT1—colon cancer	3.44e-07	4.87e-05	CbGpPWpGaD
